QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Enhancement of chemosensitivity by WEE1 inhibition in EGFR-TKIs resistant non-small cell lung cancer 期刊论文 BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 117 作者:  Liu, Di;  Gao, Ziyang;  Xu, Wen;  Lin, Ge;  Zhou, Xiao 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Non-small cell lung cancer  WEE1  Drug resistance  EGFR  Tyrosine kinase inhibitors  Chemotherapy   Immunoscore System for Predicting Clinical Outcome of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors 期刊论文 JOURNAL OF CANCER, 2018, 卷号: 9, 期号: 22 作者:  Yao, Jia-Xi;  Chen, Xiang;  Xi, Wei;  Zhu, Yan-Jun;  Wang, Hang 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 immunoscore system  renal cell carcinoma  tyrosine kinase inhibitors  prognostic factor   Histone deacetylation, as opposed to promoter methylation, results in epigenetic BIM silencing and resistance to EGFR TKI in NSCLC 期刊论文 ONCOLOGY LETTERS, 2018, 卷号: 15, 期号: 1 作者:  Zhao, Mingchuan;  Zhang, Yishi;  Li, Jiayu;  Li, Xuefei;  Cheng, Ningning 收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05 epidermal growth factor receptor-tyrosine kinase inhibitors  non-small cell lung cancer  bcl-2-like protein 11  histone deacylation  methylation   HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 卷号: 67, 期号: 1 作者:  Wang, Jiajun;  Liu, Li;  Qu, Yang;  Xi, Wei;  Xia, Yu 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Metastatic renal-cell carcinoma  Tyrosine kinase inhibitors  Human leukocyte antigen class I  Cytotoxic T lymphocyte  Survival  Biomarker   Checkpoint molecule PD-1-assisted CD8(+) T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors 期刊论文 CANCER MANAGEMENT AND RESEARCH, 2018, 卷号: 10 作者:  Yao, Jiaxi;  Xi, Wei;  Zhu, Yanjun;  Wang, Hang;  Hu, Xiaoyi 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 metastatic renal cell carcinoma  tyrosine kinase inhibitors  immune checkpoint  prognostic factor   Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors 期刊论文 WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 卷号: 24, 期号: 46 作者:  Li, Jian;  Wang, Ming;  Zhang, Bo;  Wu, Xin;  Lin, Tian-Long 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 Side effects  Gastrointestinal stromal tumor  Tyrosine kinase inhibitors  Consensus guideline  China   CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma 期刊论文 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 卷号: 36, 期号: 5 作者:  Chen, Xiang;  Liu, Li;  Wang, Jiajun;  Lin, Zhiyuan;  Xiong, Ying 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Metastatic renal cell carcinoma  CXCR1  Tyrosine kinase inhibitors  Prognosis  Therapeutic response   Prognostic and predictive value of serum carcinoembryonic antigen levels in advanced non-small cell lung cancer patients with epidermal growth factor receptor sensitive mutations and receiving tyrosine kinase inhibitors 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 41 作者:  Zhao, Xin Min;  Zhao, Jing;  Xing, Kai Lin;  Sun, Si;  Luo, Zhi Guo 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 non-small cell lung cancer  chemotherapy  epidermal growth factor receptor  tyrosine kinase inhibitors  carcinoembryonic antigen   Prognostic role of N-Acetylgalactosaminyltransferase 10 in metastatic renal cell carcinoma 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 9 作者:  Liu, Li;  Xiong, Ying;  Xi, Wei;  Wang, Jiajun;  Qu, Yang 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 metastatic renal cell carcinoma  GALNT10  prognosis  biomarker  tyrosine kinase inhibitors   Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 65 作者:  Xia, Jinjing;  Bai, Hao;  Yan, Bo;  Li, Rong;  Shao, Minhua 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 epidermal growth factor receptor (EGFR)  tyrosine kinase inhibitors (TKIs)  BIM deletion polymorphism  erlotinib  ABT-737